Is macrophages heterogeneity important in determining COVID-19 lethality?
- PMID: 32645660
- PMCID: PMC7332450
- DOI: 10.1016/j.mehy.2020.110073
Is macrophages heterogeneity important in determining COVID-19 lethality?
Abstract
COVID-19 (coronavirus disease 2019) pandemic due to infection with SARS-CoV-2 has led to the death of thousands of adults worldwide. It is now clear that the hyper-inflammatory response triggered by SARS-CoV-2 plays a major role in disease severity and lethality of the infection. Macrophages are innate immune cells that sense and respond to infections by producing a plethora of inflammatory molecules and by interacting with other inflammatory cells. Therefore, macrophages may be diriment on eliminating pathogens and promoting organ repair. However, macrophages can be a major player of the so called cytokine storm and may be damaging to the tissues. It is believed that macrophage activation syndrome is induced by SARS-CoV to be lethal. Surprisingly and fortunately few children die from COVID-19. For instance, in Italy, out of more than 30.000 deaths for COVID-19, three are children. Therefore, we must wonder why? Are macrophages different in children compared to adults? In my opinion they are different. It has been demonstrated that macrophages populate the lung in three "developmental waves", and it has been suggested that similar waves may be observed in other important organs, such as the heart and kidney. It is most likely that macrophages heterogeneity is involved in determining the severity. There are no doubts that macrophages are important in determining life or death in these patients. Comparing macrophages of children with those of adults with different degrees of disease severity is, therefore, mandatory.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
-
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.Nat Rev Immunol. 2020 Jun;20(6):355-362. doi: 10.1038/s41577-020-0331-4. Epub 2020 May 6. Nat Rev Immunol. 2020. PMID: 32376901 Free PMC article. Review.
-
Age-Related Differences in Immunological Responses to SARS-CoV-2.J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3251-3258. doi: 10.1016/j.jaip.2020.08.026. Epub 2020 Aug 27. J Allergy Clin Immunol Pract. 2020. PMID: 32861856 Free PMC article. Review.
-
Immunometabolic Status of COVID-19 Cancer Patients.Physiol Rev. 2020 Oct 1;100(4):1839-1850. doi: 10.1152/physrev.00018.2020. Epub 2020 Jul 28. Physiol Rev. 2020. PMID: 32721181 Free PMC article. Review.
-
SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.J Immunol. 2020 Sep 1;205(5):1198-1206. doi: 10.4049/jimmunol.2000642. Epub 2020 Jul 17. J Immunol. 2020. PMID: 32680957 Review.
-
The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?Front Immunol. 2020 Jun 5;11:1312. doi: 10.3389/fimmu.2020.01312. eCollection 2020. Front Immunol. 2020. PMID: 32582222 Free PMC article.
Cited by
-
Immune landscape and redox imbalance during neurological disorders in COVID-19.Cell Death Dis. 2023 Sep 6;14(9):593. doi: 10.1038/s41419-023-06102-6. Cell Death Dis. 2023. PMID: 37673862 Free PMC article. Review.
-
The Therapeutic Significance of Mesenchymal Stem Cells in COVID-19 Acute Pulmonary Respiratory Disease.Turk Thorac J. 2022 Sep;23(5):355-363. doi: 10.5152/TurkThoracJ.2022.21302. Turk Thorac J. 2022. PMID: 35943071 Free PMC article.
-
Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm.Matter. 2022 Jan 5;5(1):336-362. doi: 10.1016/j.matt.2021.09.022. Epub 2021 Oct 19. Matter. 2022. PMID: 34693277 Free PMC article.
-
Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure.Sci Rep. 2021 Oct 4;11(1):19675. doi: 10.1038/s41598-021-99102-5. Sci Rep. 2021. PMID: 34608231 Free PMC article.
-
Gender Characteristics of the Novel Coronavirus Infection (COVID-19) in Middle-Aged Adults.Sovrem Tekhnologii Med. 2021;13(4):16-24. doi: 10.17691/stm2021.13.4.02. Epub 2021 Aug 28. Sovrem Tekhnologii Med. 2021. PMID: 34603760 Free PMC article. Clinical Trial.
References
-
- Sodhi C.P., Nguyen J., Yamaguchi Y., Werts A.D., Lu P., Ladd M.R. A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to pseudomonas aeruginosa lung infection in mice. J Immunol. 2019;203(11):3000–3012. doi: 10.4049/jimmunol.1900579. - DOI - PMC - PubMed
-
- Schouten L.R., van Kaam A.H., Kohse F., Veltkamp F., Bos L.D., de Beer F.M., van Hooijdonk R.T., Horn J., Straat M., Witteveen E., Glas G.J., Wieske L., van Vught L.A., Wiewel M.A., Ingelse S.A., Cortjens B., van Woensel J.B., Bos A.P., Walther T., Schultz M.J., Wösten-van Asperen R.M. MARS consortium. Age-dependent differences in pulmonary host responses in ARDS: a prospective observational cohort study. Ann Intensive Care. 2019;9(1):55. doi: 10.1186/s13613-019-0529-4. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous